GE Healthcare and the American College of Cardiology Join Forces to Advance AI in Cardiac Care
03 June 2021 - 11:00PM
Business Wire
GE Healthcare is collaborating with the American College of
Cardiology (ACC) through support of and participation in the ACC’s
Applied Health Innovation Consortium for the purpose of building a
roadmap for Artificial Intelligence (AI) and digital technology in
cardiology and developing new strategies for improved health
outcomes.
The Consortium brings together academic, clinical, industry and
technology partners and patient advocates, to collaborate in the
digital transformation of healthcare and achieve trust in the
development of clinical evidence and guidance. GE Healthcare will
lend its unique perspective as a leading global medical technology
and digital solutions innovator in connected cardiovascular care to
this forum. GE Healthcare’s Edison platform forms the technological
basis for the company’s many AI offerings that are an integral part
of its advanced cardiac technology used by clinicians in the
diagnosis and treatment of more than 145 million hearts each
year.
The thought leadership of the ACC, the clinical depth of the
Consortium’s academic and technology partners and the product
development muscle of GE Healthcare is expected to constitute a
virtuous circle from defining impactful challenges, developing AI
models, and putting research results to practice through
implementation in disruptive clinical workflows.
“We are excited to have GE Healthcare join forces with the
Applied Health Innovation Consortium,” says John Rumsfeld, MD, PhD,
FACC, ACC Chief Innovation Officer and Chief Science & Quality
Officer. “In our mission to transform cardiovascular care and
improve heart health, GE Healthcare is a great collaborator to help
build a roadmap for AI and digital technology that bridges gaps in
clinical care.”
As the world adapts to the challenges presented by
self-isolation, reduction in hands-on medical care, and a variety
of unknowns, three main drivers of the digital transformation that
will impact care are a migration towards virtual care, increased
remote monitoring of patients via wearables and telemedicine, and
AI-driven care, including image interpretation, risk prediction,
and improved care decision-making. The Consortium intends to be a
catalyst in identifying priorities and making progress in specific
and practical ways to impact clinical care.
“We are eager to help shape the heart care pathway – from early
detection to treatment to follow-up at home – by combining our
expertise in AI and digital technologies with top clinical
leadership to advance risk prediction and decision-making support,”
says Eigil Samset, Chief Technology Scientist for Cardiology
Solutions at GE Healthcare. “Ultimately, this will enable precision
health, which is doing the right thing, at the right time for every
patient, at scale – with the ultimate goal to provide better
outcomes, delivered to more people, more cost efficiently.”
The collaboration will start tackling the overwhelming
challenges related to atrial fibrillation management along with
other care pathways in cardiology that are top of mind, including
coronary artery disease, valvular heart disease and heart
failure.
About GE Healthcare:
GE Healthcare is the $18 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology and digital
solutions innovator, GE Healthcare enables clinicians to make
faster, more informed decisions through intelligent devices, data
analytics, applications and services, supported by its Edison
intelligence platform. With over 100 years of healthcare industry
experience and around 50,000 employees globally, the company
operates at the center of an ecosystem working toward precision
health, digitizing healthcare, helping drive productivity and
improve outcomes for patients, providers, health systems and
researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, and Insights for the
latest news, or visit our website www.gehealthcare.com for more
information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210603005134/en/
Holly Roloff Holly.Roloff@ge.com +1-414-429-6998
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Mar 2024 to Apr 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2023 to Apr 2024